Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration issued a complete response letter regarding the New Drug Application for CorVue for injection. CorVue is a cardiac pharmacologic stress agent for use as an adjunct in SPECT cardiac imaging intended for use in patients with or at risk for coronary artery disease who are unable to perform a cardiac exercise stress test.


   

Today in Regulatory Issues...keeping you current

Dillione Leaving Siemens
HealthDataManagement, 03/19/10

Teva Provides Update on Generic Temodar
Teva Pharmaceutical Industries, 03/18/10

Alcon Files Form 20-F with U.S. Securities and Exchange Commission
Alcon, 03/17/10

Today in Cardiac/Hypertension...keeping you current

Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/19/10

Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Meta-Analysis of Dose–Response Characteristics of Hydrochlorothiazide and Chlorthalidone: Effects on Systolic Blood Pressure and Potassium
American Journal of Hypertension, 03/19/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address